| Name | NLRP3-IN-20 |
|---|
| Description | NLRP3-IN-20 (compound 11) is an orally available inhibitor of the NLRP3 inflammasome with an IC50 of 25 nM for IL-1β secretion. NLRP3-IN-20 has excellent pharmacokinetic properties and demonstrated significant efficacy in models of non-alcoholic steatohepatitis, fatal septic shock, and colitis[1]. |
|---|---|
| Related Catalog | |
| Target |
NLRP3[1] |
| References |
| Molecular Formula | C22H27N3O3S |
|---|---|
| Molecular Weight | 413.53 |